Table 1.
Clinical characteristics | Hsp90α <82.06 ng/mL (n=111) | Hsp90α ≥82.06 ng/mL (n=82) | P-values |
---|---|---|---|
| |||
Age (years) | 0.505 | ||
≤60 | 50 | 33 | |
>60 | 61 | 49 | |
Gender | 0.721 | ||
Male | 87 | 66 | |
Female | 24 | 16 | |
Length (cm) | 0.227 | ||
≤5 | 82 | 54 | |
>5 | 29 | 28 | |
Location | 0.975 | ||
Upper | 8 | 6 | |
Middle | 60 | 43 | |
Lower | 43 | 33 | |
Differentiation | 0.743 | ||
High | 26 | 18 | |
Moderate | 58 | 40 | |
Poor | 27 | 24 | |
T stage | 0.021 | ||
T1 | 17 | 14 | |
T2 | 25 | 5 | |
T3 | 55 | 50 | |
T4 | 14 | 13 | |
N stage | 0.011 | ||
N0 | 70 | 38 | |
N1 | 29 | 25 | |
N2 | 6 | 16 | |
N3 | 6 | 3 | |
Clinical stage | 0.016 | ||
I | 65 | 32 | |
II | 9 | 6 | |
III | 37 | 44 |
Abbreviation: ESCC, esophageal squamous cell carcinoma.